{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:40:44Z","timestamp":1790185244203,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T00:00:00Z","timestamp":1742428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Metab"],"DOI":"10.1038\/s42255-025-01252-7","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T10:08:31Z","timestamp":1742465311000},"page":"730-741","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["GLP-2 prevents antipsychotics-induced metabolic dysfunction in mice"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2038-3793","authenticated-orcid":false,"given":"Yanmin","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenzhang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuolei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huateng","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shajin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3686-7925","authenticated-orcid":false,"given":"Peihuang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2447-3529","authenticated-orcid":false,"given":"Xiaohong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9226-1982","authenticated-orcid":false,"given":"Yu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-2316","authenticated-orcid":false,"given":"Ji","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0899-8077","authenticated-orcid":false,"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,20]]},"reference":[{"key":"1252_CR1","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","volume":"382","author":"S Leucht","year":"2013","unstructured":"Leucht, S. et al. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 382, 951\u2013962 (2013).","journal-title":"Lancet"},{"key":"1252_CR2","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.genhosppsych.2008.09.009","volume":"31","author":"C-F Hung","year":"2009","unstructured":"Hung, C.-F., Huang, T.-Y. & Lin, P.-Y. Hypothermia and rhabdomyolysis following olanzapine injection in an adolescent with schizophreniform disorder. Gen. Hosp. Psychiatry 31, 376\u2013378 (2009).","journal-title":"Gen. Hosp. Psychiatry"},{"key":"1252_CR3","doi-asserted-by":"publisher","first-page":"285","DOI":"10.7861\/clinmed.2022-0113","volume":"22","author":"D Camilleri","year":"2022","unstructured":"Camilleri, D. & Fiorini, A. Lessons of the month 2: olanzapine-induced hypothermia and hand oedema. Clin. Med. (Lond.) 22, 285\u2013286 (2022).","journal-title":"Clin. Med. (Lond.)"},{"key":"1252_CR4","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1152\/ajpendo.00164.2018","volume":"316","author":"C Kowalchuk","year":"2019","unstructured":"Kowalchuk, C. et al. Antipsychotics and glucose metabolism: how brain and body collide. Am. J. Physiol. Endocrinol. Metab. 316, E1\u2013E15 (2019).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"1252_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jpsychires.2023.10.055","volume":"168","author":"T Miyakoshi","year":"2023","unstructured":"Miyakoshi, T. et al. Risk factors for abnormal glucose metabolism during antipsychotic treatment: a prospective cohort study. J. Psychiatr. Res. 168, 149\u2013156 (2023).","journal-title":"J. Psychiatr. Res."},{"key":"1252_CR6","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","volume":"7","author":"T Pillinger","year":"2020","unstructured":"Pillinger, T. et al. Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis. Lancet Psychiatry 7, 64\u201377 (2020).","journal-title":"Lancet Psychiatry"},{"key":"1252_CR7","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1176\/appi.ajp.2013.13060771","volume":"170","author":"CU Correll","year":"2013","unstructured":"Correll, C. U., Sikich, L., Reeves, G. & Riddle, M. Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long? Am. J. Psychiatry 170, 947\u2013952 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"1252_CR8","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/schbul\/sbw058","volume":"42","author":"J-P Zhang","year":"2016","unstructured":"Zhang, J.-P. et al. Pharmacogenetic associations of antipsychotic drug-related weight gain: a systematic review and meta-analysis. Schizophr. Bull. 42, 1418\u20131437 (2016).","journal-title":"Schizophr. Bull."},{"key":"1252_CR9","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1172\/JCI93362","volume":"127","author":"CC Lord","year":"2017","unstructured":"Lord, C. C. et al. The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. J. Clin. Invest. 127, 3402\u20133406 (2017).","journal-title":"J. Clin. Invest."},{"key":"1252_CR10","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202484","volume":"218","author":"L Li","year":"2021","unstructured":"Li, L. et al. The atypical antipsychotic risperidone targets hypothalamic melanocortin 4 receptors to cause weight gain. J. Exp. Med. 218, e20202484 (2021).","journal-title":"J. Exp. Med."},{"key":"1252_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36808-2","volume":"14","author":"M Flanigan","year":"2023","unstructured":"Flanigan, M. et al. Subcortical serotonin 5HT2c receptor-containing neurons sex-specifically regulate binge-like alcohol consumption, social, and arousal behaviors in mice. Nat. Commun. 14, 1800 (2023).","journal-title":"Nat. Commun."},{"key":"1252_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41593-018-0207-0","volume":"21","author":"X Li","year":"2018","unstructured":"Li, X. et al. Serotonin receptor 2c-expressing cells in the ventral CA1 control attention via innervation of the Edinger\u2013Westphal nucleus. Nat. Neurosci. 21, 1239\u20131250 (2018).","journal-title":"Nat. Neurosci."},{"key":"1252_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.pbb.2010.05.029","volume":"97","author":"S Evers","year":"2010","unstructured":"Evers, S., Calcagnoli, F., Van Dijk, G. & Scheurink, A. Olanzapine causes hypothermia, inactivity, a deranged feeding pattern and weight gain in female Wistar rats. Pharmacol. Biochem. Behav. 97, 163\u2013169 (2010).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"1252_CR14","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1146\/annurev-physiol-021113-170317","volume":"76","author":"DJ Drucker","year":"2014","unstructured":"Drucker, D. J. & Yusta, B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu. Rev. Physiol. 76, 561\u2013583 (2014).","journal-title":"Annu. Rev. Physiol."},{"key":"1252_CR15","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.cmet.2022.05.002","volume":"34","author":"C Feng","year":"2022","unstructured":"Feng, C. et al. Cold-sensitive ventromedial hypothalamic neurons control homeostatic thermogenesis and social interaction-associated hyperthermia. Cell Metab. 34, 888\u2013901. e5 (2022).","journal-title":"Cell Metab."},{"key":"1252_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42255-020-0189-6","volume":"2","author":"JE van Veen","year":"2020","unstructured":"van Veen, J. E. et al. Hypothalamic oestrogen receptor alpha establishes a sexually dimorphic regulatory node of energy expenditure. Nat. Metab. 2, 351\u2013363 (2020).","journal-title":"Nat. Metab."},{"key":"1252_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/mp.2011.109","volume":"17","author":"T Lett","year":"2012","unstructured":"Lett, T. et al. Pharmacogenetics of antipsychotic-induced weight gain: review and clinical implications. Mol. Psychiatry 17, 242\u2013266 (2012).","journal-title":"Mol. Psychiatry"},{"key":"1252_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","volume":"125","author":"GP Reynolds","year":"2010","unstructured":"Reynolds, G. P. & Kirk, S. L. Metabolic side effects of antipsychotic drug treatment\u2013pharmacological mechanisms. Pharmacol. Ther. 125, 169\u2013179 (2010).","journal-title":"Pharmacol. Ther."},{"key":"1252_CR19","doi-asserted-by":"publisher","unstructured":"Li, L. et al. Functional coupling between MC4R and Kir7.1 contributes to clozapine-induced hyperphagia. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.06.07.597973 (2024).","DOI":"10.1101\/2024.06.07.597973"},{"key":"1252_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nmeth.1808","volume":"9","author":"J Mattis","year":"2012","unstructured":"Mattis, J. et al. Principles for applying optogenetic tools derived from direct comparative analysis of microbial opsins. Nat. Methods 9, 159\u2013172 (2012).","journal-title":"Nat. Methods"},{"key":"1252_CR21","doi-asserted-by":"publisher","first-page":"4997","DOI":"10.1172\/JCI93090","volume":"128","author":"D Cui","year":"2018","unstructured":"Cui, D. et al. Macrophage migration inhibitory factor mediates metabolic dysfunction induced by atypical antipsychotic therapy. J. Clin. Invest. 128, 4997\u20135007 (2018).","journal-title":"J. Clin. Invest."},{"key":"1252_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","volume":"19","author":"JW Newcomer","year":"2005","unstructured":"Newcomer, J. W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 19, 1\u201393 (2005).","journal-title":"CNS Drugs"},{"key":"1252_CR23","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1038\/s41380-023-01982-8","volume":"28","author":"C Lu","year":"2023","unstructured":"Lu, C. et al. Atypical antipsychotics antagonize GABAA receptors in the ventral tegmental area GABA neurons to relieve psychotic behaviors. Mol. Psychiatry 28, 2107\u20132121 (2023).","journal-title":"Mol. Psychiatry"},{"key":"1252_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s002130100811","volume":"156","author":"MA Geyer","year":"2001","unstructured":"Geyer, M. A., Krebs-Thomson, K., Braff, D. L. & Swerdlow, N. R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156, 117\u2013154 (2001).","journal-title":"Psychopharmacology"},{"key":"1252_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/oxfordjournals.schbul.a033326","volume":"24","author":"NR Swerdlow","year":"1998","unstructured":"Swerdlow, N. R. & Geyer, M. A. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr. Bull. 24, 285\u2013301 (1998).","journal-title":"Schizophr. Bull."},{"key":"1252_CR26","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.pbb.2005.01.012","volume":"80","author":"V Buben\u00edkov\u00e1","year":"2005","unstructured":"Buben\u00edkov\u00e1, V., Votava, M., Hor\u00e1\u010dek, J., P\u00e1len\u00ed\u010dek, T. & Dockery, C. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Pharmacol. Biochem. Behav. 80, 591\u2013596 (2005).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"1252_CR27","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1592\/phco.22.11.841.33629","volume":"22","author":"EA Koller","year":"2002","unstructured":"Koller, E. A. & Doraiswamy, P. M. Olanzapine\u2010associated diabetes mellitus. Pharmacotherapy 22, 841\u2013852 (2002).","journal-title":"Pharmacotherapy"},{"key":"1252_CR28","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","volume":"325","author":"CE Koro","year":"2002","unstructured":"Koro, C. E. et al. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study. BMJ 325, 243 (2002).","journal-title":"BMJ"},{"key":"1252_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2125.2010.03783.x","volume":"71","author":"SK Praharaj","year":"2011","unstructured":"Praharaj, S. K., Jana, A. K., Goyal, N. & Sinha, V. K. Metformin for olanzapine\u2010induced weight gain: a systematic review and meta\u2010analysis. Br. J. Clin. Pharmacol. 71, 377\u2013382 (2011).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1252_CR30","doi-asserted-by":"publisher","first-page":"355","DOI":"10.3892\/etm.2023.12054","volume":"26","author":"O Vasiliu","year":"2023","unstructured":"Vasiliu, O. Therapeutic management of atypical antipsychotic\u2011related metabolic dysfunctions using GLP\u20111 receptor agonists: a systematic review. Exp. Ther. Med. 26, 355 (2023).","journal-title":"Exp. Ther. Med."},{"key":"1252_CR31","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.psyneuen.2014.01.018","volume":"42","author":"M He","year":"2014","unstructured":"He, M. et al. Hypothalamic histamine H1 receptor-AMPK signaling time-dependently mediates olanzapine-induced hyperphagia and weight gain in female rats. Psychoneuroendocrinology 42, 153\u2013164 (2014).","journal-title":"Psychoneuroendocrinology"},{"key":"1252_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000356119","volume":"98","author":"M Ikegami","year":"2013","unstructured":"Ikegami, M. et al. Olanzapine-induced hyperglycemia: possible involvement of histaminergic, dopaminergic and adrenergic functions in the central nervous system. Neuroendocrinology 98, 224\u2013232 (2013).","journal-title":"Neuroendocrinology"},{"key":"1252_CR33","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nrendo.2016.67","volume":"12","author":"M Lopez","year":"2016","unstructured":"Lopez, M., Nogueiras, R., Tena-Sempere, M. & Dieguez, C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat. Rev. Endocrinol. 12, 421\u2013432 (2016).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1252_CR34","doi-asserted-by":"publisher","first-page":"155335","DOI":"10.1016\/j.metabol.2022.155335","volume":"137","author":"V Ferreira","year":"2022","unstructured":"Ferreira, V. et al. Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight. Metabolism 137, 155335 (2022).","journal-title":"Metabolism"},{"key":"1252_CR35","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12996","volume":"48","author":"M L\u00f3pez","year":"2018","unstructured":"L\u00f3pez, M. Hypothalamic AMPK and energy balance. Eur. J. Clin. Invest. 48, e12996 (2018).","journal-title":"Eur. J. Clin. Invest."},{"key":"1252_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.947295","volume":"16","author":"R Zhou","year":"2022","unstructured":"Zhou, R. et al. The role of hypothalamic endoplasmic reticulum stress in schizophrenia and antipsychotic-induced weight gain: a narrative review. Front. Neurosci. 16, 947295 (2022).","journal-title":"Front. Neurosci."},{"key":"1252_CR37","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.cell.2019.09.020","volume":"179","author":"D-W Kim","year":"2019","unstructured":"Kim, D.-W. et al. Multimodal analysis of cell types in a hypothalamic node controlling social behavior. Cell 179, 713\u2013728. e17 (2019).","journal-title":"Cell"},{"key":"1252_CR38","doi-asserted-by":"publisher","unstructured":"Jiao, Z. et al. Projectome-defined subtypes and modular intra-hypothalamic subnetworks of peptidergic neurons. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.05.25.542241 (2023).","DOI":"10.1101\/2023.05.25.542241"},{"key":"1252_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107649","volume":"31","author":"H Cao","year":"2020","unstructured":"Cao, H. et al. Retinoid X receptor \u03b1 regulates DHA-dependent spinogenesis and functional synapse formation in vivo. Cell Rep. 31, 107649 (2020).","journal-title":"Cell Rep."},{"key":"1252_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.aar4983","volume":"361","author":"SX Luo","year":"2018","unstructured":"Luo, S. X. et al. Regulation of feeding by somatostatin neurons in the tuberal nucleus. Science 361, 76\u201381 (2018).","journal-title":"Science"}],"container-title":["Nature Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01252-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01252-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T22:01:58Z","timestamp":1745532118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42255-025-01252-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,20]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["1252"],"URL":"https:\/\/doi.org\/10.1038\/s42255-025-01252-7","relation":{},"ISSN":["2522-5812"],"issn-type":[{"value":"2522-5812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,20]]},"assertion":[{"value":"16 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}